Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-20-018204
Filing Date
2020-04-23
Accepted
2020-04-23 16:18:20
Documents
5
Effectiveness Date
2020-04-23

Document Format Files

Seq Description Document Type Size
1 DEFA14A hrtx-defa14a_20200423.htm DEFA14A 40463
2 GRAPHIC gz5lptbjdrpq000003.jpg GRAPHIC 33805
3 GRAPHIC gz5lptbjdrpq000001.jpg GRAPHIC 58210
4 GRAPHIC gz5lptbjdrpq000004.jpg GRAPHIC 11578
5 GRAPHIC gz5lptbjdrpq000002.jpg GRAPHIC 98735
  Complete submission text file 0001564590-20-018204.txt   320869
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33221 | Film No.: 20811226
SIC: 2834 Pharmaceutical Preparations